Information Provided By:
Fly News Breaks for August 9, 2017
THC
Aug 9, 2017 | 08:40 EDT
Baird analyst Whit Mayo believes Tenet shares "feel" oversold, but he admits there is no clear catalyst soon. He said the current environment is tough and Q3 is historically not a time to be overweight medical providers, but the company has made some real progress on a turnaround. Mayo maintained his Outperform rating and $23 price target on Tenet shares.
News For THC From the Last 2 Days
There are no results for your query THC